Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: SECONDARY HYPERPARATHYROIDISM, . Treffer: 33
2018
Friedl, C; Zitt, E
Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.
DRUG DES DEV THER. 2018; 12: 1589-1598.
Doi: 10.2147/DDDT.S134103
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Littbarski, SA; Kaltenborn, A; Gwiasda, J; Beneke, J; Arelin, V; Schwager, Y; Stupak, JV; Marcheel, IL; Emmanouilidis, N; Jäger, MD; Scheumann, GFW; Klempnauer, J; Schrem, H
Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy.
Surgery. 2018; 163(2): 373-380.
Doi: 10.1016/j.surg.2017.10.016
Web of Science
PubMed
FullText
FullText_MUG
2017
Frauscher, B; Artinger, K; Kirsch, AH; Aringer, I; Moschovaki-Filippidou, F; Kétszeri, M; Schabhüttl, C; Rainer, PP; Schmidt, A; Stojakovic, T; Fahrleitner-Pammer, A; Rosenkranz, AR; Eller, P; Eller, K
A New Murine Model of Chronic Kidney Disease-Mineral and Bone Disorder.
Int J Endocrinol. 2017; 2017(3):1659071-1659071
Doi: 10.1155/2017/1659071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Friedl, C; Reibnegger, G; Kramar, R; Zitt, E; Pilz, S; Mann, JFE; Rosenkranz, AR
Mortality in dialysis patients with cinacalcet use: A large observational registry study.
Eur J Intern Med. 2017; 42(5-6):89-95
Doi: 10.1016/j.ejim.2017.05.002
Web of Science
PubMed
FullText
FullText_MUG
Friedl, C; Zitt, E
Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Int J Nephrol Renovasc Dis. 2017; 10(9):109-122
Doi: 10.2147/IJNRD.S97637
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gwiasda, J; Kaltenborn, A; Müller, JA; Serttas, M; Scheumann, GW; Schrem, H; Jäger, MD
Ultrasound-based scores as predictors for nodular hyperplasia in patients with secondary hyperparathyroidism: a prospective validation study.
Langenbecks Arch Surg. 2017; 402(2): 295-301.
Doi: 10.1007/s00423-016-1546-5
Web of Science
PubMed
FullText
FullText_MUG
Jäger, MD; Serttas, M; Beneke, J; Müller, JA; Schrem, H; Kaltenborn, A; Ramackers, W; Ringe, BP; Gwiasda, J; Tränkenschuh, W; Klempnauer, J; Scheumann, GFW
Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.
PLoS One. 2017; 12(10): e0186093-e0186093.
Doi: 10.1371/journal.pone.0186093
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Obermüller, N; Rosenkranz, AR; Müller, HW; Hidde, D; Veres, A; Decker-Burgard, S; Weisz, I; Geiger, H
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study).
Int J Mol Sci. 2017; 18(10):
Doi: 10.3390/ijms18102057
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pronai, W; Rosenkranz, AR; Bock, A; Klauser-Braun, R; Jäger, C; Pendl, G; Hemetsberger, M; Lhotta, K
Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland - the observational TRANSIT Study.
Wien Klin Wochenschr. 2017; 129(9-10):317-328
Doi: 10.1007/s00508-016-1153-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robinson-Cohen, C; Lutsey, PL; Kleber, ME; Nielson, CM; Mitchell, BD; Bis, JC; Eny, KM; Portas, L; Eriksson, J; Lorentzon, M; Koller, DL; Milaneschi, Y; Teumer, A; Pilz, S; Nethander, M; Selvin, E; Tang, W; Weng, LC; Wong, HS; Lai, D; Peacock, M; Hannemann, A; Völker, U; Homuth, G; Nauk, M; Murgia, F; Pattee, JW; Orwoll, E; Zmuda, JM; Riancho, JA; Wolf, M; Williams, F; Penninx, B; Econs, MJ; Ryan, KA; Ohlsson, C; Paterson, AD; Psaty, BM; Siscovick, DS; Rotter, JI; Pirastu, M; Streeten, E; März, W; Fox, C; Coresh, J; Wallaschofski, H; Pankow, JS; de Boer, IH; Kestenbaum, B
Genetic Variants Associated with Circulating Parathyroid Hormone.
J Am Soc Nephrol. 2017; 28(5):1553-1565
Doi: 10.1681/ASN.2016010069
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Haffner-Luntzer, M; Heilmann, A; Heidler, V; Liedert, A; Schinke, T; Amling, M; Yorgan, TA; Vom Scheidt, A; Ignatius, A
Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton.
J Orthop Res. 2016; 34(11): 1914-1921.
Doi: 10.1002/jor.23221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31
Doi: 10.1016/j.metabol.2013.08.016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Tilz, H; Becker, JC; Legat, F; Schettini, AP; Inzinger, M; Massone, C
Allopurinol in the treatment of acquired reactive perforating collagenosis.
An Bras Dermatol. 2013; 88(1):94-97
Doi: 10.1590/s0365-05962013000100012
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806
Doi: 10.1517/14656566.2013.777041
Web of Science
PubMed
FullText
FullText_MUG
2012
Pilz, S; Kienreich, K; Drechsler, C; Ritz, E; Fahrleitner-Pammer, A; Gaksch, M; Meinitzer, A; März, W; Pieber, TR; Tomaschitz, A
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
J Clin Endocrinol Metab. 2012; 97(1):E75-9
Doi: 10.1210/jc.2011-2183
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Ritz, E; Pieske, B; Fahrleitner-Pammer, A; Kienreich, K; Horina, JH; Drechsler, C; März, W; Ofner, M; Pieber, TR; Pilz, S
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Cardiovasc Res. 2012; 94(1):10-19
Doi: 10.1093/cvr/cvs092
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A
Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336
Doi: 10.1097/TP.0b013e31823f7f68
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2011
Eller, P; Eller, K; Kirsch, AH; Patsch, JJ; Wolf, AM; Tagwerker, A; Stanzl, U; Kaindl, R; Kahlenberg, V; Mayer, G; Patsch, JR; Rosenkranz, AR
A murine model of phosphate nephropathy.
Am J Pathol. 2011; 178(5):1999-2006
Doi: 10.1016/j.ajpath.2011.01.024
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Liu, Z; Segawa, H; Aydin, C; Reyes, M; Erben, RG; Weinstein, LS; Chen, M; Marshansky, V; Fröhlich, LF; Bastepe, M
Transgenic overexpression of the extra-large Gsα variant XLαs enhances Gsα-mediated responses in the mouse renal proximal tubule in vivo.
Endocrinology. 2011; 152(4):1222-1233
Doi: 10.1210/en.2010-1034
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zitt, E; Jäger, C; Rosenkranz, AR; Eigner, M; Kodras, K; Kovarik, J; Graf, H; Pétavy, F; Horn, S; Watschinger, B
Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.
Wien Klin Wochenschr. 2011; 123(1-2):45-52
Doi: 10.1007/s00508-010-1515-x
Web of Science
PubMed
FullText
FullText_MUG
Zitt, E; Kirsch, AH; Haueis, M; Strasak, A; Neyer, U; Mayer, G; Rosenkranz, AR
The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients.
Clin Nephrol. 2011; 75(4):309-318
Doi: 10.5414/CNP75309
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Fröhlich, LF; Mrakovcic, M; Steinborn, R; Chung, UI; Bastepe, M; Jüppner, H
Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib.
Proc Natl Acad Sci U S A. 2010; 107(20): 9275-9280.
Doi: 10.1073/pnas.0910224107
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2009
Pilz, S; Tomaschitz, A; Ritz, E; Pieber, TR
Vitamin D status and arterial hypertension: a systematic review.
Nat Rev Cardiol. 2009; 6(10): 621-630.
Doi: 10.1038/nrcardio.2009.135
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2007
Dobnig, H; Piswanger-Sölkner, JC; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Riedmüller, G; Brueck, C; Fahrleitner-Pammer, A
Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
J Clin Endocrinol Metab. 2007; 92(5): 1678-1686.
Doi: 10.1210/jc.2006-2079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Hesse, M; Fröhlich, LF; Zeitz, U; Lanske, B; Erben, RG
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
Matrix Biol. 2007; 26(2): 75-84.
Doi: 10.1016/j.matbio.2006.10.003
Web of Science
PubMed
FullText
FullText_MUG
2005
Fahrleitner-Pammer, A; Obernosterer, A; Pilger, E; Dobnig, H; Dimai, HP; Leb, G; Kudlacek, S; Obermayer-Pietsch, BM
Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease.
OSTEOPOROSIS INT. 2005; 16(3): 319-324.
Doi: 10.1007/s00198-004-1693-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Raggi, P; James, G; Burke, SK; Bommer, J; Chasan-Taber, S; Holzer, H; Braun, J; Chertow, GM
Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
J Bone Miner Res. 2005; 20(5):764-772
Doi: 10.1359/JBMR.041221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2003
Berger, CE; Marteau, R; Pabinger, C; Kröner, A; Ogris, E; Engel, A
Decreased cutaneous vitamin D-synthesis in heavily melanized individuals: a rare cause for pathologic fractures of the hip.
Wien Klin Wochenschr. 2003; 115(5-6):186-190
Doi: 10.1007/BF03040308
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Kudlacek, S; Schneider, B; Peterlik, M; Leb, G; Klaushofer, K; Weber, K; Woloszczuk, W; Willvonseder, R; Austrian Study Group on Normative Values of Bone Metabolism
Assessment of vitamin D and calcium status in healthy adult Austrians.
Eur J Clin Invest. 2003; 33(4):323-331
Doi: 10.1046/j.1365-2362.2003.01127.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2002
Fahrleitner, A; Dobnig, H; Obernosterer, A; Pilger, E; Leb, G; Weber, K; Kudlacek, S; Obermayer-Pietsch, BM
Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.
J Gen Intern Med. 2002; 17(9):663-669
Doi: 10.1046/j.1525-1497.2002.11033.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science
PubMed
Google Scholar
1998
Kotzmann, H; Köller, M; Abela, C; Clodi, M; Riedl, M; Graninger, W; Niederle, B; Luger, A
Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism.
Eur J Clin Invest. 1998; 28(5): 353-358.
Doi: 10.1046/j.1365-2362.1998.00283.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1990
Kaufmann, P; Smolle, K; Winkler, H; Pogglitsch, H; Mausser, G
Special problems of nutritional therapy in chronic kidney insufficiency in the pre-dialysis stage
WIEN MED WOCHENSCHR. 1990; 140(9): 245-248.
Web of Science
PubMed